clinical trial · NCT00840073
Trandolapril 4 mg Tablet Under Non-Fasting Conditions
Teva Pharmaceuticals USA·phase1·completed·n = 50
HealthyTrandolapril 4 mg TabletsMavik® 4 mg Tablets
brief summary
The objective of this study is to evaluate the comparative bioavailability between trandolapril 4 mg tablets (test) and Mavik® 4 mg Tablets (reference) after a single-dose in healthy subjects under fed conditions.
started
Oct 1, 2004
primary completion
Nov 1, 2004
completion
Nov 1, 2004
last updated
Aug 20, 2024
detailed description
Criteria for Evaluation: FDA Bioequivalence Criteria
Statistical Methods: FDA bioequivalence statistical methods
official title
A Single-Dose, Comparative Bioavailability Study of Two Formulations of Trandolapril 4 mg Tablets Under Fed Conditions.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol